Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Lung Neoplasms 22Leukemia, Myeloid, Acute 21Breast Neoplasms 19Neoplasm Metastasis 16Pancreatic Neoplasms 15Multiple Myeloma 14Prostatic Neoplasms 12Melanoma 12Lymphoma 11Colorectal Neoplasms 11Carcinoma, Renal Cell 11Carcinoma, Non-Small-Cell Lung 11Burkitt Lymphoma 10Triple Negative Breast Neoplasms 9Urinary Bladder Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Myelodysplastic Syndromes 8Mouth Neoplasms 8Glioma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Oropharyngeal Neoplasms 7Leukemia, Lymphocytic, Chronic, B-Cell 7Laryngeal Neoplasms 7Fallopian Tube Neoplasms 7Carcinoma, Hepatocellular 7Carcinoma 7Sarcoma 6Nasopharyngeal Carcinoma 6Endometrial Neoplasms 6

Interventions

Cisplatin 4Radiotherapy 3Cetuximab 3pembrolizumab 2Surveys and Questionnaires 2Carboplatin 2olaparib 1niraparib 1fludarabine 1dostarlimab 1cemiplimab 1calcipotriene 1avelumab 1atezolizumab 1aldesleukin 1Watchful Waiting 1Tiragolumab 1Standard of Care 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Platinum 1Phlebotomy 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Fluorouracil 1Fluorodeoxyglucose F18 1Docetaxel 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Specimen Handling × 30 days × Clear all
NCT03952585 2026-06-01

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
384 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡